HILL: the efficacy and safety of hepatic arterial infusion chemotherapy with the FOLFOX regimen combined with lenvatinib and the PD-L1 inhibitor durvalumab in unresectable hepatocellular carcinoma: a prospective, single-arm, phase 2 clinical trial. - Li SH; Zuo ZJ; Lu LH; Xu LZ; Wang QX; Zhao RC; Mei J; Li JB; Zheng L; Guo RP; Wei W (Signal transduction and targeted therapy, 2026)